Results 11 to 20 of about 6,561 (215)
New England Journal of Medicine, 2005 Lentigo maligna is a premalignant melanocytic neoplasm occurring on the sun-exposed skin of the middle-aged and elderly. It is believed to represent the in situ phase of lentigo maligna melanoma and, as such, cure is usually the aim of treatment. However, factors such as site and size of lesion and patient co-morbidities may influence the treatment ...
Bernard Noel, Nathalie Kunzle
exaly +6 more sources
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment
Acta Dermato-Venereologica, 2019 Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is the gold standard but an alternative treatment is off-label topical imiquimod.
Darryl C.K.S. Tio +4 more
doaj +2 more sources
Actas Dermo-Sifiliográficas, 2022 Resumen: Imiquimod tópico ha sido utilizado como monoterapia o tratamiento adyuvante fuera de indicación para el lentigo maligno (LM). Nuestro objetivo es describir las modalidades de tratamiento, los resultados clínicos y el manejo de la recidiva en los
I. Poveda-Montoyo +4 more
doaj +1 more source
Dermatology Practical & Conceptual, 2023 Introduction: Lentigo maligna is a subtype of melanoma in situ that typically affects the head and neck region with an increasing incidence. Margin-controlled techniques, such as spaghetti technique (ST), have gained popularity over wide local excision (
Manel Martinez-Molina +8 more
doaj +1 more source
Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment [PDF]
, 2016 Background: A higher incidence of lentigo maligna (LM) recurrences on the nose was previously observed in our cohort after non-surgical treatment. Objectives: To determine histological parameters that might be related to the previously observed higher ...
Doorn, M.B.A. (Martijn) van +4 more
core +14 more sources
Long-Term Response to Imiquimod for the Treatment of Lentigo Maligna Assessed With Digital Dermoscopy. [PDF]
Dermatol Pract ConceptCaliani L, Salerni G.
europepmc +2 more sources
Synchronous conjunctival melanoma and lentigo maligna melanoma [PDF]
Anais Brasileiros de Dermatologia, 2017 : Lentigo maligna has an extensive and neoplastic character. It typically progresses slowly and may eventually develop into an invasive melanoma, which is called lentigo maligna melanoma. Ocular melanoma is the second most common type of melanoma.
Beatrice Mussio Fornazier Volpini +4 more
doaj +1 more source
[Translated article] Update on Lentigo Maligna: Diagnostic Signs and Treatment
Actas Dermo-Sifiliográficas, 2023 Lentigo maligna is an in situ cutaneous melanoma that arises in sun-damaged skin. Its most common presentation is a progressive, slow-growing, irregularly pigmented spot on the face of older patients. Although the exact percentage of lentigo maligna that
C. Requena, E. Manrique, E. Nagore
doaj +1 more source
Challenge in diagnosis and management of lentigo maligna and lentigo maligna melanoma [PDF]
JDVI (Journal of General Procedural Dermatology & Venereology Indonesia), 2017 Lentigo maligna (LM) is a subtype of melanoma in situ, which can evolve into lentigo maligna melanoma (LMM) if treated inadequately. LM and LMM are usually found on chronically sun damaged skin such as the face (cheek and nose) of the elderly on seventh ...
Ika Anggraini +4 more
doaj +1 more source
El lentigo maligno: actualización y claves en el diagnóstico y el tratamiento
Actas Dermo-Sifiliográficas, 2023 Resumen: El lentigo maligno es un melanoma cutáneo in situ que asienta en zonas con daño solar acumulado. Su presentación más habitual es como una mancha irregularmente pigmentada de crecimiento lento y progresivo localizada en la cara de un paciente ...
C. Requena, E. Manrique, E. Nagore
doaj +1 more source